CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 119 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,827 | -32.6% | 1,824,387 | -1.9% | 0.03% | -30.0% |
| Q2 2023 | $59,123 | +21.1% | 1,859,787 | -7.1% | 0.04% | +14.3% |
| Q1 2023 | $48,819 | -22.8% | 2,001,568 | -0.2% | 0.04% | -28.6% |
| Q4 2022 | $63,272 | -99.9% | 2,006,068 | +0.2% | 0.05% | +8.9% |
| Q3 2022 | $56,561,000 | – | 2,001,437 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |